THE LATE THERAPEUTIC RESULTS PRODUCED BY LOW VOLTAGE ROENTGEN RAYS AND OTHER FORMS OF THERAPY IN CERTAIN BENIGN CHRONIC SKIN DISEASES*

Similar documents
five series of cases were studied. Many of the patients treated by one

PACKAGE LEAFLET: INFORMATION FOR THE USER. Flutarzole 0,05% w/w cream, Fluticasone propionate

Contents. QAaptm-2. CAaptei-3. CAaptm-4. Cftapte%-5. Qfiaptvt-6. QhapteK-7. Qkaptefc-8 Clinical Immunology and Allergy 71

What are the functions of the integumentary system? What are some disorders of the integumentary system?

TOPICAL USE OF CHLORQUINALDOL* HARRY M. ROBINSON, JR., M.D. AND MARK B. HOLLANDER, M.D. PROCEDURE

The treatment of acne vulgaris with Intraderm Sulfur was reported by

STUDIES OF THE ETHER-SOLUBLE SUBSTANCES ON THE HUMAN SKIN

and virus infections notable improvements, too, have been attained in our capacity and ability to suppress inflammation, dampen the effects of allergy

The Role of Low-Potency Topical Steroids in Day-to-Day Practice

EVALUATION OF TOPICAL DICHLOROXYQUINALDINE (STEROSAN) AS A THERAPEUTIC AGENT IN DERMATOLOGY* ARTHUR J. TRONSTEIN M.D.**

DESCRIPTIONS FOR MED 3 ROTATIONS Dermatology A3S

Acne by the numbers. The charts that follow provide topline data on how acne contributes to the overall burden of skin disease.

Periocular skin cancer

Psoriasis by the numbers

Research Paper Outline

D E R M A T O L O G Y

Patricia C. McCormack, M.D., F.A.A.D.

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

If you are looking for the book by Donna Flinn;Eczema;Eczema Remedies;Eczema Cure;Eczema Free Books;Eczema For Women;Eczema Guide;Eczema Menu and

A CLINICAL EVALUATION OF THE EFFECTIVENESS OF HYDRYLLIN IN THE TREATMENT OF A VARIETY OF DERMATOSES*

Clinic Clinic Information Suitable for Referral Not Suitable for Referral

Quality of Life of Saudi Patients with Dermatologic Disorders

If looking for a book Psoriasis Cure: Treatments, Natural Remedies and Best Home Managements (Skin Disease, Skin Problems, Skin Diseases and

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Bullous diseases by the numbers

Topical Doxepin Prior Authorization with Quantity Limit Program Summary

Table of Contents: Part 1 Medical Dermatology. Chapter 1 Acneiform Disorders. Acne. Acne Vulgaris. Pomade Acne. Steroid Acne

Dr Ravi C. Ratnavel DM (Oxon) FRCP (UK)

Diagnosis And Treatment Of Seborrheic Dermatitis

WR SKIN. DERMATOLOGY

Eczema Itchin' For A Cure By Suzy Cohen

Disorders of the vulva

COLLOIDAL SILVER. Compiled by. Campbell M Gold (2009) CMG Archives --()-- IMPORTANT

UNIVERSITY OF MICHIGAN HOSPITALS AND HEALTH CENTERS. Delineation of Privileges Department of Dermatology

MALE GENITAL (PENIS) LICHEN SCLEROSUS

EDUCATION & TRAINING CURRICULUM

CONDITIONS OF THE SKIN

Precision diagnostics for personalized melanoma care

SKIN-CAP IN TREATMENT OF PATIENTS WITH PSORIASIS

Alcortin A (iodoquinol and hydrocortisone), Novacort (hydrocortisone and pramoxine)

Phototherapy and Photochemotherapy Treatment (Ultraviolet A [PUVA] and B [UBV])

Sandostene an(! Sandostene in Combination with Calcium: Clinical Effect in Various Dermatoses

Douglas N. Robins, M.D. Ameriderm Research

INTERNAL MEDICINE FOR PRIMARY CARE PHYSICIANS. San Diego, California Hotel Del Coronado. August 23-26, Participating Faculty

The Queen Victoria Hospital, East Grinstead

SQUAMOUS CELL CARCINOMA

PRODUCT INFORMATION ELEUPHRAT CREAM, OINTMENT AND LOTION. Betamethasone dipropionate equivalent to betamethasone 0.5 mg/g (0.

Integumentary System

Corporate Medical Policy

DATA SHEET. Betamethasone dipropionate equivalent to betamethasone 0.5mg/g (0.05% w/w).

Important Information about Mohs Micrographic Surgery

Subspecialty Rotation: Dermatology

Vulval dermatoses. Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough

Package leaflet: Information for the user. Fluticrem 0.05% cream Fluticasone propionate

Blue light therapy. Blue light therapy has shown to have a positive effect on the following: Why to choose blue light?

Course Title Diploma Course in Dermatology and Dermatosurgery. Master Degree: Diploma Course in Dermatology and Dermatosurgery

Healing Adult Acne: Your Guide To Clear Skin And Self-Confidence By Richard G. Fried READ ONLINE

Rosacea by the numbers

ICD 10 Codes. L82.1 Seborrheic Keratosis L82.0 Irritated Seborrheic Keratosis

A STUDY OF AN ANTIHISTAMINE WITH DELAYED ACTION IN THE TREATMENT OF PRURITIC DERMATOSES

ACNE. What are the aims of this leaflet?

Efficacy of Concomitant Use of PUVA and Methotrexate in Disease Clearance Time in Plaque Type Psoriasis

The Cochrane Skin - Core Outcome Set Initiative (CS-COUSIN)

Treating your skin condition with Narrowband ultraviolet B radiation (NB-UVB)

Ancillary Material: ORT215 Summer 2016 Computer Answer Sheet. Registration number from U-Card (9 digits) - to be completed by student

Chapter 19 Hidradenitis Suppurativa

UWMC Roosevelt Clinic Rotation Goals 2011 Procedural Dermatology Fellowship Program 1

BEST FACE CREAM FOR ACCUTANE

PRODUCT MONOGRAPH DIPROSONE. Betamethasone Dipropionate Cream, Merck Standard, 0.05% W/W betamethasone (as dipropionate)

PRODUCT MONOGRAPH. Betamethasone dipropionate USP. 0.5 mg Cream, Ointment and Lotion. Topical corticosteroid

What caused this refractory pruritic eruption? Patient Presentation

Connective tissue diseases by the numbers

Clinical Policy: Phototherapy and Photochemotherapy for Dermatological Conditions Reference Number: CP.MP. 441

Smoking and the Skin

GENERAL OVERVIEW OF TYPES OF HAIR LOSS AND ALOPECIA TELOGEN EFFLUVIUM

LIFE EXPECTANCY AND INCIDENCE OF MALIGNANT DISEASE

C.V. Updated on November, 2015

Melanocytic Tumors

Making decisions about available treatments

Dr. Mohammed T Omar Associate professor CAMS Mobile: Office: 2074

(3) but this fact has not prevented the almost complete replacement of the INVESTIGATIVE STUDIES ON COLORADO SHALE OIL*

Cancer Association of South Africa (CANSA)

THE RELATIVE INCIDENCE OF OOPHORECTOMY IN WOMEN WITH AND WITHOUT CARCINOMA OF THE BREAST'

MOHS MICROGRAPHIC SURGERY: AN OVERVIEW

NORMAL SKIN REACTIONS TO ULTRAVIOLET LIGHT

Skin cancer by the numbers

Department of Dermatology. (Seoul National University Hospital)

Chapter Two. The study of Acanthosis nigricans

Endocrinology Sample Case

FURTHER OBSERVATIONS ON THE ORGANS OF MICE PAINTED WITH CARCINOGENIC AGENTS

SUMMARY OF PRODUCT CHARACTERISTICS

Hair and nail disorders by the numbers

Common Dermatological Conditions in Adults in Ghana. Margaret Lartey FWACP

b) SKILLS The student should be able to

Steroid use in managing your child s Atopic Eczema

Dr Emmy Babor GPSI Dermatology

DIPROSONE OV Cream and Ointment do not contain preservatives, parabens or lanolin.

SUMMARY OF PRODUCT CHARACTERISTICS. Excipient with known effect Cetyl alcohol For the full list of excipients, see section 6.1.

INTRODUCTION 1. DERMATOLOGY

Prescribing Information

Transcription:

THE LATE THERAPEUTIC RESULTS PRODUCED BY LOW VOLTAGE AND OTHER FORMS OF THERAPY IN CERTAIN BENIGN CHRONIC SKIN DISEASES* RUDOLF L. BAER, M.D., ALEXANDER BOROTA, M.D. AND MARION B. SULZBERGER, M.D. INTRODUCTION During the past three years we have conducted a follow-up study in 2907 patients who, 5 to 23 years previously, had been under treatment at the Skin and Cancer Unit of the University Hospital (1) for a variety of benign and malignant skin conditions. These patients were divided into two groups; namely one group of 1521 patients who had been treated with roentgen rays and in many cases also with other commonly used forms of dermatologic therapy; and another group of 1386 patients who had been treated with other generally accepted forms of treatment but who had not received roentgen ray treatment. A first objective of this follow-up study was to ascertain, in a number of patients sufficiently large to permit statistically valid conclusions, whether or not roentgen ray treatments, as generally given by dermatologists in the United States in selected cases of benign dermatoses, produce undesirable or dangerous sequelae. This was done by examining the skin areas which had been treated years before for possible roentgen sequelae; and by comparing the incidence of malignant growths in the treated areas in the patients who had received roentgen ray treatments with their incidence in patients treated with other modalities. Some of the results of this part of the study have been reported elsewhere (1). They can be summarized as follows: superficial roentgen ray treatments in fractional doses of 85 r or less given up to a total of 1,000 r did not produce roentgen sequelae. Superficial roentgen ray treatments in fractional doses of 85 r or less, totalling more than 1,000 r units, produced mild, non-malignant sequelae in about 1 out of 87 cases treated. These exceptional cases appeared to be those which, in addition to the roentgen irradiation, had had years of repeated, excessive or unusually prolonged exposures to sunlight. There was no evidence that superficial roentgen ray treatments in dosage now generally employed by dermatologists in the treatment of "benign" skin diseases predispose the irradiated skin areas to the development of malignant alterations. The present report deals with another purpose of the follow-up study, namely a comparison between the long-term therapeutic results achieved with superficial roentgen rays and those achieved with other commonly used dermatologic * From the Department of Dermatology and Syphulology (Dr. Marion B. Sulzberger, Chairman) of the New York University Post-Graduate Medical School and the Skin and Cancer Unit of the New York University Hospital. This study was supported in part by a grant under contract 80(30-1)-890 with the U. S. Atomic Energy Commission. Read before the thirteenth Annual Meeting of the Society for Investigative Dermatology Inc., Chicago, Ill. June 8, 1952. 325

326 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY therapeutic measures. In particular, we attempted to find the answers to the following questions: 1. How does the therapeutic efficacy of superficial roentgen ray treatments compare with that of other accepted forms of therapy in selected common skin diseases for which no "specific" measures are available at present? 2. Are there significant differences in the long term results achieved in those cases which received relatively small doses and those which received relatively large doses of superficial roentgen rays? 3. What is the comparative incidence of scarring in cases of acne vulgaris treated with and without roentgen rays? INVESTIGATIONS AND RESULTS Eleven hundred and seven patients suffering from the following benign, chronic dermatoses were included in the comparative evaluation: Acne Vulgaris 384 cases Eczema 343 cases Psoriasis 211 cases Chronic Lichenified Dermatitis* 169 cases These are among the most prevalent dermatoses (2, 3), and although they do not influence the length of life, they are of extreme importance because of their incapacitating nature in some cases, the transient or permanent disfigurement they cause, their psychological effects on the patients, and, indirectly, also their effects on the social and economic status of the patients. Yet for none of these dermatoses is there available a standardized "specific" form of therapy which is effective in all cases. A comparison of the therapeutic results of superficial roentgen ray therapy and other non-specific forms of therapy was therefore of the greatest interest. A. Acne vulgaris 259 patients were treated with roentgen rays. (In addition some other forms of topical or systemic therapy were used in many of these cases.) 125 patients were not treated with roentgen rays but with other forms of local, systemic and minor surgical therapy, including lotions, salves, ultraviolet and cold quartz lamp treatments, CO2 slush treatments, and various kinds of injections. B. Eczema 190 patients were treated with roentgen rays. (In addition some other forms of topical or systemic therapy were used in many of these cases.) 153 patients were not treated with roentgen rays but with other forms of local or systemic therapy, including ointments, lotions, ultraviolet lamp treatments and various types of injections. * Including, among others, atopic dermatitis, lichenified eczema, lichen chronicus simplex, etc.

LATE THERAPEUTIC RESULTS FROM 327 TABLE I Acne Vulgaris. Incidence of permanent lcure* (259 CASES) NOT (125 CAsEs) Permanently cured 230 (89%) 95 (76%) Not permanently cured 29 (11%) 30 (24%) * "Cure" as used in the present report designates that the area was free from active lesions at the time of the follow-up examination and that the patient made no mention of recurrence during the intervening period. However, it does not imply that this cessation of the disease was necessarily or solely due to the therapeutic measures employed. TABLE II Acne Vulgaris. Incidence of scarring due to disease or treatment in tcured* cases (230 CASES) NOT (95 CASES) Scarring present No scarring present * See footnote to Table L 115 (50%) 115 (50%) 55 (58%) 40 (42%) TABLE III Acne Vulgaris. Incidence of permanent cure* as related to do8e of roentgen rays administered TOTAL DOSE CURED (230 CASES) NOT CURED (29 CASES) 1000 r or less loolrtolsoor l5olrto2000r 200lrandabove 151 (84%) 72 4 3 TABLE IV Eczema. Incidence of permanent cure* (190 CASES) 29 (16%) NOT (153 CASES) Permanently cured Not permanently cured 110 (58%) 80 (42%) 68 (44%) 85 (56%) TABLE V Eczema. Incidence of permanent "cure"5 as related to dose of roentgen rays administered TOTAL DOSE CURED (110 CASES) NOT CURED (80 CASES) 1000 r or less 1001 r to 1500 r 1500 r and above 96 (58%) 13 (60%) 1 70 (42%) 9 (40%) 1

328 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY C. P8oriasis 71 patients were treated with roentgen rays. (In addition some other forms of topical or systemic therapy were used in many of these cases.) 140 patients were not treated with roentgen rays but with other forms of local or systemic therapy including ointments, pastes, alpine and cold quartz irradation and injections. TABLE VI Psoriasis. Incidence of permanent cure* (71 CASES) NOT ROENTUEN RAYS (140 CASES) Permanently cured 22 (31%) 23 (17%) Not permanently cured 49 (69%) 117 (83%) TABLE VII Psoriasis. Incidence of permanent cure* as related to dose of roentgen rays administered TOTAL DOSE CORED (22 CASES) NOT CURED (49 CASES) 1000 r or less loolrtol500r l5olrto2000r 18 (29%) 2 2 44 (71%) 4 1 D. Chronic Lichenified Dermalitis* 117 patients were treated with roentgen rays. (In addition some other forms of topical or systemic therapy were used in many of these cases.) 52 patients were not treated with roentgen rays but with different forms of local or systemic therapy including various topical preparations, alpine lamp irradiation and injections. TABLE VIII Chronic Lichenified Dermatitis. Incidence of permanent cure* (117 CASES) NOT (52 CASES) Permanently cured 53 (45%) 13 (25%) Not permanently cured 64 (55%) 39 (75%) * The group of cases of chronic lichenified dermatitis ("neurodermatitis") is rather heterogeneous and includes among others atopic dermatitis, lichenified eczema, lichen chroni cus simplex (localized form), etc.

LATE THERAPEUTIC RESULTS FROM 329 TABLE IX Chronic Lichenified Dermititis. Incidence of permanent "cure* as related to dose of roentgen rays administered TOTAL DOSE CURED (53 cases) NOT CUREH (64 cases) 1000 r or less 44 (49%) 45 (51%) 1001 r to 1500 r 8 (44%) 10 (56%) 1501 r and above 1 9 * See footnote to Table I COMMENT The most striking finding in this study is the very significant difference in "permanent duresi* between the patients treated with superficial roentgen rays and those treated with other measures. For, as Table X indicates, 65% were cured of the patients who had been treated with roentgen rays, (and in addition in some cases with other measures), as compared with 42% of those treated with other measures alone. The "other measures" employed in many of the patients who had received roentgen therapy were probably, in general, the same as those employed in patients who had not received roentgen radiation. Obviously these TABLE X Summary of therapeutic results (1107 cases) NOT Cured Failed Cured Failed Acne Eczema Psoriasis Chronic lichenified dermatitis 230 (89%) 110 (58%) 22 (31%) 53 (45%) 29 (11%) 80 (42%) 49 (69%) 64 (55%) 95 (79%) 68 (44%) 23 (17%) 13 (25%) 30 (21%) 85 (56%) 117 (83%) 39 (75%) Total 415 (65%) 222 (35%) 199 (42%) 271 (58%) other therapeutic measures may account for the same percentage of cures in the X-ray treated group as in the other group of patients. Morever, among the patients in both groups there must have been some whose eruptions had cleared permanently independently from (or even despite of?) the roentgen ray or other treatment used. Nevertheless, the statistically very significantf difference between the 65% cured among those who had received roentgen ray treatments, and 42% cured among those treated only with other measures, indicates that roentgen rays may be a powerful therapeutic agent not only, as is so often said, t Chi-square 56.0; P much less than 0.01.

330 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY for 'temporary" relief, but also for producing permanent clearing of the eruptions with which we are concerned here. The difference in the percentage of permanent cures achieved is greatest in psoriasis (31% vs. 17% see Table VI), and chronic lichenified dermatitis (45% vs. 25% see Table VII), next greatest in eczema (58% vs. 44% see table IV), and smallest in acne vulgaris (89% vs. 77% see Table I). This is not too surprising since acne vulgaris is the only dermatosis among the four investigated here which is known to clear spontaneously in most cases, usually when the patient reaches his late teens or early twenties. In our previously published study (1) and in additional investigations since then, it was found that fractional doses of superficial roentgen rays up to a total of 1,000 r per skin area did not produce sequelae, while fractional doses totalling more than 1,000 r produced very mild and superficial sequelae in 1 out of 87 patients. Therefore, it was interesting to know whether, leaving out all considerations regarding the safety factor involved, it is an advantage to administer total doses of more than 1,000 r in the benign dermatoses discussed in this report. Among the acne vulgaris patients of those who had received 1,000 r or less had not been cured while all patients who had received 1,000 r or more had been cured. While this absolute difference would be unlikely to hold in a larger series of acne patients it at least suggests that the larger doses of roentgen rays have a very definite effect in bringing acne vulgaris to permanent healing in patients who would otherwise continue to have acne for many years. Contrariwise, in the eczema, psoriasis and chronic lichenified dermatitis cases there was no evidence that doses above 1,000 r bring about a higher percentage of cures. However, it appears worth mentioning here that, among the 22 psoriasis patients who had received roentgen ray treatments and whose lesions had been cured, there were 3 who had developed new lesions in areas which had not been involved at the previous time of observation. Another extremely important question, which we believe can be answered from our studies, is whether, in acne, roentgen ray treatments tend to bring about more scarring than would occur if such treatments were not given. We have found during many years of private and clinic practice that the medical and lay public firmly believe that roentgen ray treatments increase the tendency to scarring in acne cases. The figures in Table II convincingly contradict this widely held misconception. As a matter of fact the incidence of scarring in the roentgen ray treated group was lower than in the control group. However, the figures in Table II demonstrate the very disappointing fact that some skin changes of cosmetic significance will occur in at least of all cases of acne, no matter what type of treatment is used. The data submitted here compare two treated groups and not a treated with an untreated group, so that no comparisons can be made regarding the incidence of sequelae in a roentgen ray treated group and an entirely untreated group. It is possible that in both groups of acne cases studied by us, injudicious surgical or other treatment may have been the cause of some of the scarring. The figure of 50% or more of acne cases showing scarring appears to us much higher than we would have believed on the basis of our experiences in our

LATE THERAPEUTIC RESULTS FROM 331 private practices. There is a possibility that the cases of acne vulgaris which seek treatment of the Skin and Cancer Unit may, as a group, be much more severe than those which seek help in our private practices. SUMMARY (1) The long term therapeutic efficacy of roentgen ray treatments and of other therapeutic measures was compared in 1107 patients who 5 to 23 years previously had been under treatment for acne vulgaris, eczema, psoriasis or chronic lichenifled dermatitis. Six hundred and thirty seven patients had been treated with roentgen rays (and in many cases also with other therapeutic agents) and 470 had been treated with similar therapeutic measures excluding roentgen rays. In the roentgen ray treated group, 65% were found to be cured* as compared with only 42% in the group in which roentgen rays had not been used. The difference in incidence of "cures" achieved was greatest in psoriasis (31% with and 17% without roentgen rays) and chronic lichenifled dermatitis (45% with and 25% without roentgen rays), intermediate in eczema (58% with and 44% without roentgen rays) and was smallest in acne (89% with and 77% without roentgen rays). (2) Except in acne there was no evidence that fractional doses of roentgen rays totaffing more than 1,000 r were more effective in producing long lasting "cure" than doses totalling less than 1,000 r. In acne one sixth of the patients who had received a total dose of less than 1,000 r still showed signs of activity while none of the patients who had received more than 1,000 r gave evidence of residual activity. (3) There was no evidence that in acne the administration of superficial roentgen rays in doses up to more than 2,000 r produced more scarring than did other therapeutic procedures. Some evidence of scarring was seen in 50% of the cases treated with roentgen rays and in 58% of cases which had received no roentgen rays but only other therapeutic measures. CONCLUSIONS 1) Superficial roentgen ray therapy in moderate doses is not only effective in producing temporary and symptomatic benefit in acne, eczema, psoriasis and chronic lichenified dermatitis but is also of significant help in bringing about long lasting or permanent freedom from active lesions in these dermatoses. 2) There is no evidence that superficial roentgen ray therapy, as compared with other commonly used therapeutic measures, increases the tendency to scarring in acne patients. REFERENCES 1. SULZBERGER, MARION B., BARR, R. L. AND BOROTA, A., "Do Roentgen ray treatments as given by skin specialists produce cancers or other sequelae?" Archives of Dermatology and Syphilology, vol. 65, page 639, June 1952. * See footnote t' Table I.

332 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 2. SULZBEROER, MARION B., AND BARR, R. L., The Year Book of Dermatology and Syphilology, Chicago, The Year Book Publishers, Inc., 1947, page 24. 3. GOODMAN, H., Statistics of the ten most common skin diseases. Archives of Dermatology and Syphilology, vol. 20, page 186, August 1934. DISCUSSION DR. RUDOLF L. BAER, New York, N. Y.: Since no one present challenges our findings, I shall take a moment to restate what we found in our study on the incidence of sequelae that might be caused by superficial x-rays, when given in the manner generally used by skin specialists in the United States. That part of the study has been presented previously by Dr. Sulzberger at another meeting. We found the following: In not a single patient who received a total dose of 1000 r or less, given in the usual fractional doses, were roentgen sequelae found. In those patients who received a total dose of more than 1000 r in fractional doses, we found that 1 out of every 87 patients had developed some roentgen sequelae. These were all of a mild nature no carcinomas and no ulcerations were seen. What can one conclude from the results? One can conclude that when roentgen rays are used in moderate doses and when they are used by properly trained skin specialists they are absolutely safe and they afford not only symptomatic temporary relief, but they may have a more or less profound beneficial effect on the future course of the eruption. I believe that these results should help us in defending a most valuable therapeutic measure against attacks particularly on the part of so-called cancer experts.